Prostate News Archive
15-Feb-2009
Androgen Ablation Augments Prostate Cancer Vaccine Immunogenicity Only When Applied After Immunization (Medical News Today)
UroToday.com - In the online edition of The prostate, a group of researchers from the Norris Comprehensive Cancer Center at USC reported on the relationship between androgen ablation (AA) and the efficacy of vaccine immunogenicity. In the AA setting, testosterone-mediated immune suppression is reduced and prostate antigens are released. Researchers ID Biomarker for Fatal Prostate Cancer (HealthDay via Yahoo! News)
FRIDAY, Feb. 13 (HealthDay News) -- A newly identified biomarker for fatal prostate cancer may help guide men trying to decide whether or not to undergo treatment for the disease. Pelvic Lymph Node Dissection (Extended Vs Standard) And Prostate Cancer (Medical News Today)
UroToday.com - The purpose of this article was to review the recent medical papers about the role and potential benefits of extended lymphadenectomy in prostate cancer. We analyzed clinical prognostic factors on lymphatic disease, imaging techniques used in clinical staging, and reasons for performing an ileo-obturator lymphadenectomy versus an extended lymphadenectomy. North American Scientific Sells Prostate Line (San Fernando Valley Business Journal)
North American Scientific Inc. will sell its prostate brachytherapy product line to Best Theratronics Ltd. in a deal worth $5 million. Items in the line include Prospera brachytherapy seeds, SurTRAK needles and strands and accessories used to treat prostate cancer. Visually Directed Transrectal High Intensity Focused Ultrasound For The Treatment Of Prostate Cancer: A Preliminary ... (Medical News Today)
UroToday.com - Radical prostatectomy is the gold standard in patients with organ-confined prostate cancer, with excellent long-term survival rates, even if surgery is associated with significant morbidity.
Back to Prostate News Archive
